US2018162800A1PendingUtilityA1
Use of the Irritating Principal Oleocanthal in Olive Oil, as Well as Structurally and Functionally Similar Compounds
Assignee: MONELL CHEMICAL SENSES CENTREPriority: May 9, 2005Filed: Jan 24, 2018Published: Jun 14, 2018
Est. expiryMay 9, 2025(expired)· nominal 20-yr term from priority
A61P 9/00A61P 43/00A61P 7/06A61P 3/10A61P 9/10A61P 39/06A61P 25/00A61P 31/00A61P 29/00A61P 25/06A61P 31/02A61P 27/02A61P 27/16A61P 35/00A61P 25/28A61P 31/04A61P 13/12A61P 1/02A61P 11/06A61P 17/02A61P 11/04A61P 21/00A61P 21/04A61P 1/04A61P 17/00A61P 1/00A61P 17/06A61P 11/00C07C 67/58A61K 31/222C07C 67/56C07C 67/313C07C 69/738
47
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention provides methods of synthesizing the purified enantiomers of oleocanthal. The invention further provides methods of using oleocanthals in various formulations including, food additives; pharmaceuticals; cosmetics; animal repellants; and discovery tools for mammalian irritation receptor genes, gene products, alleles, splice variants, alternate transcripts and the like.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of treating a patient with an inflammatory disorder comprising administering to a patient with an inflammatory disorder an effective amount of a composition comprising a compound of the formula:
wherein:
R1 and R4 are independently H or —OR5;
R2 and R3 are independently CHO or COOR5;
R5 is a H, C 1 -C 5 alkyl, or a glycoside;
X is O, NH or CH 2 ;
Y is C═CHCH 3 or CH—COOR5;
Z is C═O or CH—OR5;
A is CH 2 or CH—COOR5;
wherein said composition alleviates inflammation in said patient.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.